Cornerstone Capital Inc Q2 2026 Portfolio Activity: Significant Buys and Sales Observed

Cornerstone Capital, Inc's portfolio saw notable shifts in the second quarter of 2026, with significant purchases including Pfizer (PFE) and new positions in Intel (INTC), ASE Technology (ASX), XLY, and XLV. The investor also disposed of shares in Corning (GLW).

By Insiderset.Aug 4, 2026, 8:57 PM
Cornerstone Capital Inc Q2 2026 Portfolio Activity: Significant Buys and Sales Observed

Cornerstone Capital Inc reported its portfolio activity for the quarter ending June 30, 2026.

Prominent Purchases Observed by Cornerstone Capital Inc

Careful analysis of Cornerstone Capital Inc's portfolio changes for Q2 2026 reveals several significant investment activities. The investor demonstrated notable buying interest, particularly in healthcare and technology sectors.

  • Pfizer (PFE): Cornerstone Capital significantly increased its position in PFIZER INC during the quarter. The holding count for PFE rose by 193,179 shares, representing a substantial +258.5% change from the previous period.
  • ASE Technology (ASX): Cornerstone Capital established a new position in ASE TECHNOLOGY HLDG CO LTD, acquiring all 44,531 shares during Q2. This resulted in an impressive +100% change for this technology holding.
  • Intel (INTC): The investor also initiated a new position in INTEL CORP, adding 18,252 shares to the portfolio. This was another +100% increase for this technology stock.
  • Consumer Staples ETF (XLY): Cornerstone Capital added a position in SELECT SECTOR SPDR TR, increasing its holdings by 13,339 shares. This represented a +100% change for this exchange-traded fund.
  • Healthcare ETF (XLV): The investor also purchased additional shares in VOYAGER HEALTHCARE INC, adding 13,339 shares to the portfolio. This was a +2.79% increase for this healthcare ETF.
  • Johnson & Johnson (JNJ): Cornerstone Capital increased its stake in JOHNSON & JOHNSON by 17,233 shares during the quarter. This was a +17.62% change for this healthcare holding.
  • AptarGroup (ATR): The investor boosted its position in APTARGROUP INC by acquiring 15,276 shares. This led to an approximate +8.32% increase for this healthcare stock.

Notable Dispositions and Share Reductions

In contrast to the buying activities, Cornerstone Capital also disposed of certain holdings during Q2 2026:

  • Corning (GLW): The investor significantly reduced its position in CORNING INC. The share count decreased by 112,780 units (-27.17%) during the quarter.
  • Shake Shack (SHAK): Cornerstone Capital sold shares in SHAKE SHACK INC, resulting in a -37.23% change from prior period holdings.
  • Simpson Manufacturing (SSD): The investor disposed of some Simpson Manufacturing shares, leading to a +35.39% change percent for this position during the quarter.

Overall Portfolio Dynamics

The observed changes reflect Cornerstone Capital Inc's active investment strategy in Q2 2026. The portfolio maintained its focus on large-cap technology and healthcare stocks, while also incorporating exposure to ETFs through positions like XLY and XLV.

Conclusion: Cornerstone Capital's Investment Footprint

In summary, the second quarter of 2026 saw Cornerstone Capital Inc engage in substantial buying activities across several sectors. The investor notably increased its stake in Pfizer (PFE), acquired new positions in Intel (INTC) and ASE Technology (ASX), and added to ETF holdings like XLY and XLV. Conversely, the portfolio experienced a reduction in Corning (GLW) shares during this period.